NAT-GEFITINIB
NAT-GEFITINIB
Approved
DIN Number
02491796
Drug Class
Human
Market Date
Nov 13, 2019
Company
HC
natco pharma (canada) inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02491796
AIG Number0149783001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EB01 GEFITINIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
GEFITINIBActive
Strength: 250 MG
Monograph: GEFITINIB